symbol,statement_type,period_end,line_item,value
WOCKPHARMA.NS,income,2025-03-31 00:00:00,Tax Effect Of Unusual Items,0.0
WOCKPHARMA.NS,income,2025-03-31 00:00:00,Tax Rate For Calcs,0.3
WOCKPHARMA.NS,income,2025-03-31 00:00:00,Normalized EBITDA,4550000000.0
WOCKPHARMA.NS,income,2025-03-31 00:00:00,Total Unusual Items,0.0
WOCKPHARMA.NS,income,2025-03-31 00:00:00,Total Unusual Items Excluding Goodwill,0.0
WOCKPHARMA.NS,income,2025-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,-470000000.0
WOCKPHARMA.NS,income,2025-03-31 00:00:00,Reconciled Depreciation,2170000000.0
WOCKPHARMA.NS,income,2025-03-31 00:00:00,Reconciled Cost Of Revenue,11320000000.0
WOCKPHARMA.NS,income,2025-03-31 00:00:00,EBITDA,4550000000.0
WOCKPHARMA.NS,income,2025-03-31 00:00:00,EBIT,2380000000.0
WOCKPHARMA.NS,income,2025-03-31 00:00:00,Net Interest Income,-2540000000.0
WOCKPHARMA.NS,income,2025-03-31 00:00:00,Interest Expense,2540000000.0
WOCKPHARMA.NS,income,2025-03-31 00:00:00,Interest Income,
WOCKPHARMA.NS,income,2025-03-31 00:00:00,Normalized Income,-470000000.0
WOCKPHARMA.NS,income,2025-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,-470000000.0
WOCKPHARMA.NS,income,2025-03-31 00:00:00,Total Expenses,28320000000.0
WOCKPHARMA.NS,income,2025-03-31 00:00:00,Rent Expense Supplemental,
WOCKPHARMA.NS,income,2025-03-31 00:00:00,Diluted Average Shares,155629139.0
WOCKPHARMA.NS,income,2025-03-31 00:00:00,Basic Average Shares,155629139.0
WOCKPHARMA.NS,income,2025-03-31 00:00:00,Diluted EPS,-3.02
WOCKPHARMA.NS,income,2025-03-31 00:00:00,Basic EPS,-3.02
WOCKPHARMA.NS,income,2025-03-31 00:00:00,Diluted NI Availto Com Stockholders,-470000000.0
WOCKPHARMA.NS,income,2025-03-31 00:00:00,Net Income Common Stockholders,-470000000.0
WOCKPHARMA.NS,income,2025-03-31 00:00:00,Otherunder Preferred Stock Dividend,0.0
WOCKPHARMA.NS,income,2025-03-31 00:00:00,Net Income,-470000000.0
WOCKPHARMA.NS,income,2025-03-31 00:00:00,Minority Interests,100000000.0
WOCKPHARMA.NS,income,2025-03-31 00:00:00,Net Income Including Noncontrolling Interests,-570000000.0
WOCKPHARMA.NS,income,2025-03-31 00:00:00,Net Income Discontinuous Operations,
WOCKPHARMA.NS,income,2025-03-31 00:00:00,Net Income Continuous Operations,-570000000.0
WOCKPHARMA.NS,income,2025-03-31 00:00:00,Tax Provision,410000000.0
WOCKPHARMA.NS,income,2025-03-31 00:00:00,Pretax Income,-160000000.0
WOCKPHARMA.NS,income,2025-03-31 00:00:00,Other Non Operating Income Expenses,620000000.0
WOCKPHARMA.NS,income,2025-03-31 00:00:00,Special Income Charges,0.0
WOCKPHARMA.NS,income,2025-03-31 00:00:00,Other Special Charges,
WOCKPHARMA.NS,income,2025-03-31 00:00:00,Write Off,0.0
WOCKPHARMA.NS,income,2025-03-31 00:00:00,Impairment Of Capital Assets,
WOCKPHARMA.NS,income,2025-03-31 00:00:00,Restructuring And Mergern Acquisition,
WOCKPHARMA.NS,income,2025-03-31 00:00:00,Net Non Operating Interest Income Expense,-2540000000.0
WOCKPHARMA.NS,income,2025-03-31 00:00:00,Total Other Finance Cost,
WOCKPHARMA.NS,income,2025-03-31 00:00:00,Interest Expense Non Operating,2540000000.0
WOCKPHARMA.NS,income,2025-03-31 00:00:00,Interest Income Non Operating,
WOCKPHARMA.NS,income,2025-03-31 00:00:00,Operating Income,1800000000.0
WOCKPHARMA.NS,income,2025-03-31 00:00:00,Operating Expense,17000000000.0
WOCKPHARMA.NS,income,2025-03-31 00:00:00,Other Operating Expenses,8320000000.0
WOCKPHARMA.NS,income,2025-03-31 00:00:00,Depreciation And Amortization In Income Statement,2170000000.0
WOCKPHARMA.NS,income,2025-03-31 00:00:00,Amortization,
WOCKPHARMA.NS,income,2025-03-31 00:00:00,Depreciation Income Statement,2170000000.0
WOCKPHARMA.NS,income,2025-03-31 00:00:00,Selling General And Administration,
WOCKPHARMA.NS,income,2025-03-31 00:00:00,Selling And Marketing Expense,
WOCKPHARMA.NS,income,2025-03-31 00:00:00,General And Administrative Expense,
WOCKPHARMA.NS,income,2025-03-31 00:00:00,Rent And Landing Fees,
WOCKPHARMA.NS,income,2025-03-31 00:00:00,Gross Profit,18800000000.0
WOCKPHARMA.NS,income,2025-03-31 00:00:00,Cost Of Revenue,11320000000.0
WOCKPHARMA.NS,income,2025-03-31 00:00:00,Total Revenue,30120000000.0
WOCKPHARMA.NS,income,2025-03-31 00:00:00,Operating Revenue,30120000000.0
WOCKPHARMA.NS,income,2024-03-31 00:00:00,Tax Effect Of Unusual Items,-435000000.0
WOCKPHARMA.NS,income,2024-03-31 00:00:00,Tax Rate For Calcs,0.3
WOCKPHARMA.NS,income,2024-03-31 00:00:00,Normalized EBITDA,2530000000.0
WOCKPHARMA.NS,income,2024-03-31 00:00:00,Total Unusual Items,-1450000000.0
WOCKPHARMA.NS,income,2024-03-31 00:00:00,Total Unusual Items Excluding Goodwill,-1450000000.0
WOCKPHARMA.NS,income,2024-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,-4630000000.0
WOCKPHARMA.NS,income,2024-03-31 00:00:00,Reconciled Depreciation,2230000000.0
WOCKPHARMA.NS,income,2024-03-31 00:00:00,Reconciled Cost Of Revenue,11650000000.0
WOCKPHARMA.NS,income,2024-03-31 00:00:00,EBITDA,1080000000.0
WOCKPHARMA.NS,income,2024-03-31 00:00:00,EBIT,-1150000000.0
WOCKPHARMA.NS,income,2024-03-31 00:00:00,Net Interest Income,-3050000000.0
WOCKPHARMA.NS,income,2024-03-31 00:00:00,Interest Expense,3050000000.0
WOCKPHARMA.NS,income,2024-03-31 00:00:00,Interest Income,60000000.0
WOCKPHARMA.NS,income,2024-03-31 00:00:00,Normalized Income,-3615000000.0
WOCKPHARMA.NS,income,2024-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,-4630000000.0
WOCKPHARMA.NS,income,2024-03-31 00:00:00,Total Expenses,28510000000.0
WOCKPHARMA.NS,income,2024-03-31 00:00:00,Rent Expense Supplemental,360000000.0
WOCKPHARMA.NS,income,2024-03-31 00:00:00,Diluted Average Shares,144461778.0
WOCKPHARMA.NS,income,2024-03-31 00:00:00,Basic Average Shares,144461778.0
WOCKPHARMA.NS,income,2024-03-31 00:00:00,Diluted EPS,-32.05
WOCKPHARMA.NS,income,2024-03-31 00:00:00,Basic EPS,-32.05
WOCKPHARMA.NS,income,2024-03-31 00:00:00,Diluted NI Availto Com Stockholders,-4630000000.0
WOCKPHARMA.NS,income,2024-03-31 00:00:00,Net Income Common Stockholders,-4630000000.0
WOCKPHARMA.NS,income,2024-03-31 00:00:00,Otherunder Preferred Stock Dividend,0.0
WOCKPHARMA.NS,income,2024-03-31 00:00:00,Net Income,-4630000000.0
WOCKPHARMA.NS,income,2024-03-31 00:00:00,Minority Interests,90000000.0
WOCKPHARMA.NS,income,2024-03-31 00:00:00,Net Income Including Noncontrolling Interests,-4720000000.0
WOCKPHARMA.NS,income,2024-03-31 00:00:00,Net Income Discontinuous Operations,
WOCKPHARMA.NS,income,2024-03-31 00:00:00,Net Income Continuous Operations,-4720000000.0
WOCKPHARMA.NS,income,2024-03-31 00:00:00,Tax Provision,520000000.0
WOCKPHARMA.NS,income,2024-03-31 00:00:00,Pretax Income,-4200000000.0
WOCKPHARMA.NS,income,2024-03-31 00:00:00,Other Non Operating Income Expenses,830000000.0
WOCKPHARMA.NS,income,2024-03-31 00:00:00,Special Income Charges,-1450000000.0
WOCKPHARMA.NS,income,2024-03-31 00:00:00,Other Special Charges,660000000.0
WOCKPHARMA.NS,income,2024-03-31 00:00:00,Write Off,790000000.0
WOCKPHARMA.NS,income,2024-03-31 00:00:00,Impairment Of Capital Assets,
WOCKPHARMA.NS,income,2024-03-31 00:00:00,Restructuring And Mergern Acquisition,
WOCKPHARMA.NS,income,2024-03-31 00:00:00,Net Non Operating Interest Income Expense,-3050000000.0
WOCKPHARMA.NS,income,2024-03-31 00:00:00,Total Other Finance Cost,140000000.0
WOCKPHARMA.NS,income,2024-03-31 00:00:00,Interest Expense Non Operating,3050000000.0
WOCKPHARMA.NS,income,2024-03-31 00:00:00,Interest Income Non Operating,60000000.0
WOCKPHARMA.NS,income,2024-03-31 00:00:00,Operating Income,-530000000.0
WOCKPHARMA.NS,income,2024-03-31 00:00:00,Operating Expense,16860000000.0
WOCKPHARMA.NS,income,2024-03-31 00:00:00,Other Operating Expenses,8340000000.0
WOCKPHARMA.NS,income,2024-03-31 00:00:00,Depreciation And Amortization In Income Statement,2230000000.0
WOCKPHARMA.NS,income,2024-03-31 00:00:00,Amortization,
WOCKPHARMA.NS,income,2024-03-31 00:00:00,Depreciation Income Statement,2230000000.0
WOCKPHARMA.NS,income,2024-03-31 00:00:00,Selling General And Administration,2300000000.0
WOCKPHARMA.NS,income,2024-03-31 00:00:00,Selling And Marketing Expense,1250000000.0
WOCKPHARMA.NS,income,2024-03-31 00:00:00,General And Administrative Expense,1050000000.0
WOCKPHARMA.NS,income,2024-03-31 00:00:00,Rent And Landing Fees,360000000.0
WOCKPHARMA.NS,income,2024-03-31 00:00:00,Gross Profit,16330000000.0
WOCKPHARMA.NS,income,2024-03-31 00:00:00,Cost Of Revenue,11650000000.0
WOCKPHARMA.NS,income,2024-03-31 00:00:00,Total Revenue,27980000000.0
WOCKPHARMA.NS,income,2024-03-31 00:00:00,Operating Revenue,27980000000.0
WOCKPHARMA.NS,income,2023-03-31 00:00:00,Tax Effect Of Unusual Items,-12768000.0
WOCKPHARMA.NS,income,2023-03-31 00:00:00,Tax Rate For Calcs,0.0048
WOCKPHARMA.NS,income,2023-03-31 00:00:00,Normalized EBITDA,1850000000.0
WOCKPHARMA.NS,income,2023-03-31 00:00:00,Total Unusual Items,-2660000000.0
WOCKPHARMA.NS,income,2023-03-31 00:00:00,Total Unusual Items Excluding Goodwill,-2660000000.0
WOCKPHARMA.NS,income,2023-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,-5590000000.0
WOCKPHARMA.NS,income,2023-03-31 00:00:00,Reconciled Depreciation,2510000000.0
WOCKPHARMA.NS,income,2023-03-31 00:00:00,Reconciled Cost Of Revenue,11110000000.0
WOCKPHARMA.NS,income,2023-03-31 00:00:00,EBITDA,-810000000.0
WOCKPHARMA.NS,income,2023-03-31 00:00:00,EBIT,-3320000000.0
WOCKPHARMA.NS,income,2023-03-31 00:00:00,Net Interest Income,-2980000000.0
WOCKPHARMA.NS,income,2023-03-31 00:00:00,Interest Expense,2920000000.0
WOCKPHARMA.NS,income,2023-03-31 00:00:00,Interest Income,40000000.0
WOCKPHARMA.NS,income,2023-03-31 00:00:00,Normalized Income,-2942768000.0
WOCKPHARMA.NS,income,2023-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,-5590000000.0
WOCKPHARMA.NS,income,2023-03-31 00:00:00,Total Expenses,27950000000.0
WOCKPHARMA.NS,income,2023-03-31 00:00:00,Rent Expense Supplemental,340000000.0
WOCKPHARMA.NS,income,2023-03-31 00:00:00,Diluted Average Shares,144064321.0
WOCKPHARMA.NS,income,2023-03-31 00:00:00,Basic Average Shares,144064321.0
WOCKPHARMA.NS,income,2023-03-31 00:00:00,Diluted EPS,-38.79
WOCKPHARMA.NS,income,2023-03-31 00:00:00,Basic EPS,-38.79
WOCKPHARMA.NS,income,2023-03-31 00:00:00,Diluted NI Availto Com Stockholders,-5590000000.0
WOCKPHARMA.NS,income,2023-03-31 00:00:00,Net Income Common Stockholders,-5590000000.0
WOCKPHARMA.NS,income,2023-03-31 00:00:00,Otherunder Preferred Stock Dividend,0.0
WOCKPHARMA.NS,income,2023-03-31 00:00:00,Net Income,-5590000000.0
WOCKPHARMA.NS,income,2023-03-31 00:00:00,Minority Interests,620000000.0
WOCKPHARMA.NS,income,2023-03-31 00:00:00,Net Income Including Noncontrolling Interests,-6210000000.0
WOCKPHARMA.NS,income,2023-03-31 00:00:00,Net Income Discontinuous Operations,
WOCKPHARMA.NS,income,2023-03-31 00:00:00,Net Income Continuous Operations,-6210000000.0
WOCKPHARMA.NS,income,2023-03-31 00:00:00,Tax Provision,-30000000.0
WOCKPHARMA.NS,income,2023-03-31 00:00:00,Pretax Income,-6240000000.0
WOCKPHARMA.NS,income,2023-03-31 00:00:00,Other Non Operating Income Expenses,90000000.0
WOCKPHARMA.NS,income,2023-03-31 00:00:00,Special Income Charges,-2660000000.0
WOCKPHARMA.NS,income,2023-03-31 00:00:00,Other Special Charges,2530000000.0
WOCKPHARMA.NS,income,2023-03-31 00:00:00,Write Off,0.0
WOCKPHARMA.NS,income,2023-03-31 00:00:00,Impairment Of Capital Assets,
WOCKPHARMA.NS,income,2023-03-31 00:00:00,Restructuring And Mergern Acquisition,130000000.0
WOCKPHARMA.NS,income,2023-03-31 00:00:00,Net Non Operating Interest Income Expense,-2980000000.0
WOCKPHARMA.NS,income,2023-03-31 00:00:00,Total Other Finance Cost,100000000.0
WOCKPHARMA.NS,income,2023-03-31 00:00:00,Interest Expense Non Operating,2920000000.0
WOCKPHARMA.NS,income,2023-03-31 00:00:00,Interest Income Non Operating,40000000.0
WOCKPHARMA.NS,income,2023-03-31 00:00:00,Operating Income,-1490000000.0
WOCKPHARMA.NS,income,2023-03-31 00:00:00,Operating Expense,16840000000.0
WOCKPHARMA.NS,income,2023-03-31 00:00:00,Other Operating Expenses,5220000000.0
WOCKPHARMA.NS,income,2023-03-31 00:00:00,Depreciation And Amortization In Income Statement,2510000000.0
WOCKPHARMA.NS,income,2023-03-31 00:00:00,Amortization,240000000.0
WOCKPHARMA.NS,income,2023-03-31 00:00:00,Depreciation Income Statement,2270000000.0
WOCKPHARMA.NS,income,2023-03-31 00:00:00,Selling General And Administration,2440000000.0
WOCKPHARMA.NS,income,2023-03-31 00:00:00,Selling And Marketing Expense,1340000000.0
WOCKPHARMA.NS,income,2023-03-31 00:00:00,General And Administrative Expense,1100000000.0
WOCKPHARMA.NS,income,2023-03-31 00:00:00,Rent And Landing Fees,340000000.0
WOCKPHARMA.NS,income,2023-03-31 00:00:00,Gross Profit,15350000000.0
WOCKPHARMA.NS,income,2023-03-31 00:00:00,Cost Of Revenue,11110000000.0
WOCKPHARMA.NS,income,2023-03-31 00:00:00,Total Revenue,26460000000.0
WOCKPHARMA.NS,income,2023-03-31 00:00:00,Operating Revenue,26460000000.0
WOCKPHARMA.NS,income,2022-03-31 00:00:00,Tax Effect Of Unusual Items,-585600000.0
WOCKPHARMA.NS,income,2022-03-31 00:00:00,Tax Rate For Calcs,0.32
WOCKPHARMA.NS,income,2022-03-31 00:00:00,Normalized EBITDA,3010000000.0
WOCKPHARMA.NS,income,2022-03-31 00:00:00,Total Unusual Items,-1830000000.0
WOCKPHARMA.NS,income,2022-03-31 00:00:00,Total Unusual Items Excluding Goodwill,-1830000000.0
WOCKPHARMA.NS,income,2022-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,-2440000000.0
WOCKPHARMA.NS,income,2022-03-31 00:00:00,Reconciled Depreciation,2470000000.0
WOCKPHARMA.NS,income,2022-03-31 00:00:00,Reconciled Cost Of Revenue,12670000000.0
WOCKPHARMA.NS,income,2022-03-31 00:00:00,EBITDA,1180000000.0
WOCKPHARMA.NS,income,2022-03-31 00:00:00,EBIT,-1290000000.0
WOCKPHARMA.NS,income,2022-03-31 00:00:00,Net Interest Income,-2930000000.0
WOCKPHARMA.NS,income,2022-03-31 00:00:00,Interest Expense,2820000000.0
WOCKPHARMA.NS,income,2022-03-31 00:00:00,Interest Income,60000000.0
WOCKPHARMA.NS,income,2022-03-31 00:00:00,Normalized Income,-1195600000.0
WOCKPHARMA.NS,income,2022-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,-2440000000.0
WOCKPHARMA.NS,income,2022-03-31 00:00:00,Total Expenses,31590000000.0
WOCKPHARMA.NS,income,2022-03-31 00:00:00,Rent Expense Supplemental,310000000.0
WOCKPHARMA.NS,income,2022-03-31 00:00:00,Diluted Average Shares,120965007.0
WOCKPHARMA.NS,income,2022-03-31 00:00:00,Basic Average Shares,120560315.0
WOCKPHARMA.NS,income,2022-03-31 00:00:00,Diluted EPS,-20.24
WOCKPHARMA.NS,income,2022-03-31 00:00:00,Basic EPS,-20.24
WOCKPHARMA.NS,income,2022-03-31 00:00:00,Diluted NI Availto Com Stockholders,-2440000000.0
WOCKPHARMA.NS,income,2022-03-31 00:00:00,Net Income Common Stockholders,-2440000000.0
WOCKPHARMA.NS,income,2022-03-31 00:00:00,Otherunder Preferred Stock Dividend,0.0
WOCKPHARMA.NS,income,2022-03-31 00:00:00,Net Income,-2440000000.0
WOCKPHARMA.NS,income,2022-03-31 00:00:00,Minority Interests,350000000.0
WOCKPHARMA.NS,income,2022-03-31 00:00:00,Net Income Including Noncontrolling Interests,-2790000000.0
WOCKPHARMA.NS,income,2022-03-31 00:00:00,Net Income Discontinuous Operations,0.0
WOCKPHARMA.NS,income,2022-03-31 00:00:00,Net Income Continuous Operations,-2790000000.0
WOCKPHARMA.NS,income,2022-03-31 00:00:00,Tax Provision,-1320000000.0
WOCKPHARMA.NS,income,2022-03-31 00:00:00,Pretax Income,-4110000000.0
WOCKPHARMA.NS,income,2022-03-31 00:00:00,Other Non Operating Income Expenses,30000000.0
WOCKPHARMA.NS,income,2022-03-31 00:00:00,Special Income Charges,-1830000000.0
WOCKPHARMA.NS,income,2022-03-31 00:00:00,Other Special Charges,1830000000.0
WOCKPHARMA.NS,income,2022-03-31 00:00:00,Write Off,
WOCKPHARMA.NS,income,2022-03-31 00:00:00,Impairment Of Capital Assets,
WOCKPHARMA.NS,income,2022-03-31 00:00:00,Restructuring And Mergern Acquisition,
WOCKPHARMA.NS,income,2022-03-31 00:00:00,Net Non Operating Interest Income Expense,-2930000000.0
WOCKPHARMA.NS,income,2022-03-31 00:00:00,Total Other Finance Cost,170000000.0
WOCKPHARMA.NS,income,2022-03-31 00:00:00,Interest Expense Non Operating,2820000000.0
WOCKPHARMA.NS,income,2022-03-31 00:00:00,Interest Income Non Operating,60000000.0
WOCKPHARMA.NS,income,2022-03-31 00:00:00,Operating Income,510000000.0
WOCKPHARMA.NS,income,2022-03-31 00:00:00,Operating Expense,18920000000.0
WOCKPHARMA.NS,income,2022-03-31 00:00:00,Other Operating Expenses,5560000000.0
WOCKPHARMA.NS,income,2022-03-31 00:00:00,Depreciation And Amortization In Income Statement,2470000000.0
WOCKPHARMA.NS,income,2022-03-31 00:00:00,Amortization,190000000.0
WOCKPHARMA.NS,income,2022-03-31 00:00:00,Depreciation Income Statement,2470000000.0
WOCKPHARMA.NS,income,2022-03-31 00:00:00,Selling General And Administration,3280000000.0
WOCKPHARMA.NS,income,2022-03-31 00:00:00,Selling And Marketing Expense,1800000000.0
WOCKPHARMA.NS,income,2022-03-31 00:00:00,General And Administrative Expense,1480000000.0
WOCKPHARMA.NS,income,2022-03-31 00:00:00,Rent And Landing Fees,310000000.0
WOCKPHARMA.NS,income,2022-03-31 00:00:00,Gross Profit,19430000000.0
WOCKPHARMA.NS,income,2022-03-31 00:00:00,Cost Of Revenue,12670000000.0
WOCKPHARMA.NS,income,2022-03-31 00:00:00,Total Revenue,32100000000.0
WOCKPHARMA.NS,income,2022-03-31 00:00:00,Operating Revenue,32100000000.0
WOCKPHARMA.NS,income,2021-03-31 00:00:00,Tax Effect Of Unusual Items,
WOCKPHARMA.NS,income,2021-03-31 00:00:00,Tax Rate For Calcs,
WOCKPHARMA.NS,income,2021-03-31 00:00:00,Normalized EBITDA,
WOCKPHARMA.NS,income,2021-03-31 00:00:00,Total Unusual Items,
WOCKPHARMA.NS,income,2021-03-31 00:00:00,Total Unusual Items Excluding Goodwill,
WOCKPHARMA.NS,income,2021-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,
WOCKPHARMA.NS,income,2021-03-31 00:00:00,Reconciled Depreciation,
WOCKPHARMA.NS,income,2021-03-31 00:00:00,Reconciled Cost Of Revenue,
WOCKPHARMA.NS,income,2021-03-31 00:00:00,EBITDA,
WOCKPHARMA.NS,income,2021-03-31 00:00:00,EBIT,
WOCKPHARMA.NS,income,2021-03-31 00:00:00,Net Interest Income,
WOCKPHARMA.NS,income,2021-03-31 00:00:00,Interest Expense,
WOCKPHARMA.NS,income,2021-03-31 00:00:00,Interest Income,210000000.0
WOCKPHARMA.NS,income,2021-03-31 00:00:00,Normalized Income,
WOCKPHARMA.NS,income,2021-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,
WOCKPHARMA.NS,income,2021-03-31 00:00:00,Total Expenses,
WOCKPHARMA.NS,income,2021-03-31 00:00:00,Rent Expense Supplemental,300000000.0
WOCKPHARMA.NS,income,2021-03-31 00:00:00,Diluted Average Shares,
WOCKPHARMA.NS,income,2021-03-31 00:00:00,Basic Average Shares,
WOCKPHARMA.NS,income,2021-03-31 00:00:00,Diluted EPS,
WOCKPHARMA.NS,income,2021-03-31 00:00:00,Basic EPS,
WOCKPHARMA.NS,income,2021-03-31 00:00:00,Diluted NI Availto Com Stockholders,
WOCKPHARMA.NS,income,2021-03-31 00:00:00,Net Income Common Stockholders,
WOCKPHARMA.NS,income,2021-03-31 00:00:00,Otherunder Preferred Stock Dividend,
WOCKPHARMA.NS,income,2021-03-31 00:00:00,Net Income,
WOCKPHARMA.NS,income,2021-03-31 00:00:00,Minority Interests,
WOCKPHARMA.NS,income,2021-03-31 00:00:00,Net Income Including Noncontrolling Interests,
WOCKPHARMA.NS,income,2021-03-31 00:00:00,Net Income Discontinuous Operations,9850000000.0
WOCKPHARMA.NS,income,2021-03-31 00:00:00,Net Income Continuous Operations,
WOCKPHARMA.NS,income,2021-03-31 00:00:00,Tax Provision,
WOCKPHARMA.NS,income,2021-03-31 00:00:00,Pretax Income,
WOCKPHARMA.NS,income,2021-03-31 00:00:00,Other Non Operating Income Expenses,
WOCKPHARMA.NS,income,2021-03-31 00:00:00,Special Income Charges,
WOCKPHARMA.NS,income,2021-03-31 00:00:00,Other Special Charges,-950000000.0
WOCKPHARMA.NS,income,2021-03-31 00:00:00,Write Off,257400000.0
WOCKPHARMA.NS,income,2021-03-31 00:00:00,Impairment Of Capital Assets,1420000000.0
WOCKPHARMA.NS,income,2021-03-31 00:00:00,Restructuring And Mergern Acquisition,
WOCKPHARMA.NS,income,2021-03-31 00:00:00,Net Non Operating Interest Income Expense,
WOCKPHARMA.NS,income,2021-03-31 00:00:00,Total Other Finance Cost,60000000.0
WOCKPHARMA.NS,income,2021-03-31 00:00:00,Interest Expense Non Operating,
WOCKPHARMA.NS,income,2021-03-31 00:00:00,Interest Income Non Operating,210000000.0
WOCKPHARMA.NS,income,2021-03-31 00:00:00,Operating Income,
WOCKPHARMA.NS,income,2021-03-31 00:00:00,Operating Expense,
WOCKPHARMA.NS,income,2021-03-31 00:00:00,Other Operating Expenses,
WOCKPHARMA.NS,income,2021-03-31 00:00:00,Depreciation And Amortization In Income Statement,
WOCKPHARMA.NS,income,2021-03-31 00:00:00,Amortization,190000000.0
WOCKPHARMA.NS,income,2021-03-31 00:00:00,Depreciation Income Statement,
WOCKPHARMA.NS,income,2021-03-31 00:00:00,Selling General And Administration,2670000000.0
WOCKPHARMA.NS,income,2021-03-31 00:00:00,Selling And Marketing Expense,1320000000.0
WOCKPHARMA.NS,income,2021-03-31 00:00:00,General And Administrative Expense,1350000000.0
WOCKPHARMA.NS,income,2021-03-31 00:00:00,Rent And Landing Fees,300000000.0
WOCKPHARMA.NS,income,2021-03-31 00:00:00,Gross Profit,
WOCKPHARMA.NS,income,2021-03-31 00:00:00,Cost Of Revenue,
WOCKPHARMA.NS,income,2021-03-31 00:00:00,Total Revenue,
WOCKPHARMA.NS,income,2021-03-31 00:00:00,Operating Revenue,
